311 results on '"Reduzzi, Carolina"'
Search Results
2. Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine
3. Isolation and Genomic Analysis of Circulating Tumor Cell Clusters in Cancer Patients
4. Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
5. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors
6. Clinical Perspectives in the Use of Liquid Biopsy in Metastatic Breast Cancer
7. Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring?
8. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
9. Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications
10. Analysis of single circulating tumor cells (CTCs) to infer phenotype and genome changes in response to therapeutic pressures in biliary tract cancer
11. Circulating tumor cells: from biotech innovation to clinical utility
12. Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer
13. Clinical Perspectives in the Use of Liquid Biopsy in Metastatic Breast Cancer
14. FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphoma
15. Racial differences in genomic profiles and targeted treatment use in ER+ HER2- metastatic breast cancer.
16. The Role of Liquid Biopsy as a Catalyst for Sustained Progress in Precision Oncology – Perspective of The Young Committee of The International Society of Liquid Biopsy
17. Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer
18. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs
19. Better together: circulating tumor cell clustering in metastatic cancer
20. Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion
21. Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis
22. Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer
23. Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen
24. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer
25. Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics
26. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial
27. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs
28. Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
29. Supplementary Video S20 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
30. Supplementary Excel S3 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
31. Data from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
32. Supplementary Tables S1-S2 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
33. Supplementary Figures S1-S17 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
34. Data from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
35. Supplementary Tables 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
36. Supplemental Figure 3 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
37. Supplemental Figure 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
38. Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
39. Supplemental Figure 2 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
40. Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
41. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.
42. Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
43. Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis
44. Abstract 3385: A pipeline for mRNA analysis on circulating tumor cells (CTCs) collected and stored in preservative tubes
45. Abstract 304: Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer
46. The implication of Epstein-Barr virus latent membrane protein 1 on the composition and prognostic significance of the tumor microenvironment of classical Hodgkin lymphoma
47. Abstract P6-10-15: Targeting MARCKS in inflammatory breast cancer increased paclitaxel sensitivity
48. Abstract P2-26-06: Association between CK+/CD45+ circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) alterations in advanced breast cancer patients
49. Abstract PD10-01: PD10-01 Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach
50. Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.